"NVIGEN...announces its new application in RNA sequencing (RNAseq) that promises to transform our understanding of cellular dynamics within tissues...NVIGEN’s magnetic nanoparticle capture is poised to usher in a new era in tissue RNAseq. One of the most remarkable features of this approach is the ability to provide not only spatial but also temporal resolution. Researchers can now sample individual cells multiple times, capturing longitudinal information that was previously unattainable."
"NVIGEN...unveil its groundbreaking technology, NVIGEN X®-Precision Medicine Biomarker Profiling, at the San Antonio Breast Cancer Symposium from December 5 to 9."
"Nvigen...presented data last week at the San Antonio Breast Cancer Symposium showing that its Nvigen X Cancer Precision Profiling assay accurately monitors dynamic changes in circulating tumor DNA, or ctDNA...In a poster presented at SABCS, Nvigen showed performance metrics data of Nvigen X and a case study from an ongoing 150-person pilot study of the assay's performance in breast cancer patients."